GEn1E Lifesciences appoints François Nader, MD as Chair of its Board of Directors

GEn1E Lifesciences appoints François Nader, MD as Chair of its Board of Directors

Notified -...

AB2 Bio Completes Enrolment in Pivotal Phase 3 Trial of

AB2 Bio Completes Enrolment in Pivotal Phase 3 Trial of

Topline pivotal Phase 3 results expected during second half of 2023Potential new treatment option in ultra-rare, life-threatening, primarily pediatric......

menu
menu